EP272: How a $10B Company Turned De-Extinction into a Platform

30 Dec 2025 · 30 min · 17 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Colossal’s de-extinction platform—how the company scaled genome engineering into a business, plus future monetization and communication strategy.

Guests/backgrounds

The episode is a conversation with Colossal’s founder/leader (serial entrepreneur; previously built “a handful of software companies,” later moved into de-extinction). He cites working with governments, conservation partners, indigenous groups, and field work (e.g., South Island of New Zealand). No other guest is clearly identified in the transcript.

Key claims

Colossal has proven an end-to-end de-extinction/species-preservation system using dire wolves and woolly-mouse trait engineering. The company plans a portfolio of resurrected species and rewilding, and is shifting from “technology achievements” to monetizable platforms (spinning out companies, government contracts, carbon credits/ecotourism). De-extinction is framed as engineering, not discovery.

Notable examples

dire wolves; woolly mice; FormBio (“drug resurrection” for failed drugs using AI/modeling); artificial womb/ex-utero growth; mammoths, thylacines, moas, dodos, Tasmanian thylacine; “Hemsworth brothers” as pop-culture partners; “half a trillion media impressions.”

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

The Woolly Mammoth's Cultural Significance

0:45 to 2:34

Discussion on the cultural icon status of the woolly mammoth and its potential reintroduction.

“I don't know if there's a cooler science project on the planet.”

Colossal's Vision and Future Goals

2:34 to 3:51

Exploring Colossal's goals in genome engineering and species reintroduction.

“So we've successfully spun out three companies, two of which we've announced, right?”

Business Model and Technology Development

3:51 to 5:00

Insights into Colossal's business model and technology pipeline for de-extinction.

“So drugs that failed in the different stages of manufacturing or the clinical trials, we can actually help identify, use AI, use some of our modeling to understand why those drugs failed and hopefully resurrect them.”

Applications Beyond De-Extinction

5:00 to 6:04

Potential applications of de-extinction technologies in pharmaceuticals and healthcare.

“And the idea that we could build a company that created a lot of value, create impact for conservation, and then also inspire the next generation if we were successful about science, it just seemed like the right fit.”

Diverse Applications and Spinouts

6:04 to 7:38

Discussion on Colossal's spinouts and their varied applications in biotechnology.

“How are you going so quickly and with so much complexity?”

The Journey to Starting Colossal

7:38 to 8:43

Exploration of the motivations and background behind starting Colossal.

“And you can't just be the only torchbearer.”

Building a Fast-Growing Startup

8:43 to 10:51

Insights on leadership, team dynamics, and the company's growth culture.

“teams in computational biology and embryology and animal husbandry.”

Investor Alignment and Challenges

10:51 to 12:45

Discussion on investor alignment and challenges faced in Colossal's growth.

“They're like, we'll give you money to go start another software thing, but like, we, we don't get like, we don't get this.”

Engineering Perspective on De-Extinction

12:45 to 14:01

Explanation of how Colossal approaches de-extinction as an engineering problem.

“It's not like, okay, we can get to Alpha Sensari if we solve faster than light travel, right?”

Creating a Pop Culture Brand Around Science

14:01 to 16:45

Learn how the company blends pop culture with scientific concepts to engage the public.

“we think of software products, only these being biological products that the world would get excited about.”
Show all 17 chapters

Positive Impact of Media on Science Acceptance

17:26 to 20:13

Explore how media impressions have raised awareness for Colossal's projects.

“And I bet we found this kind of like perfect, like smoothie blend of how to talk about it.”

Kids as Catalysts for Scientific Interest

20:13 to 22:14

Understand the role of children in generating interest and support for conservation.

“You know, if I do the math, I left a 60 impression per human being on the planet, which is crazy.”

Future of De-Extinction and Ecosystem Balance

22:14 to 24:15

Learn about the potential future of de-extinction and its ecological importance.

“What's the next decade for colossal look like?”

Building Resilience Against Extinction

24:15 to 25:14

Discover the importance of having contingency plans for biodiversity preservation.

“then need a de-extinction toolkit and not have it, right?”

Navigating Challenges in Entrepreneurship

25:14 to 28:00

Gain insights on maintaining conviction and resilience during tough times in business.

“Tell me about how you align with later stages of a capital market and also maybe your capital markets plans.”

The Mindset of an Entrepreneur

28:00 to 29:38

Learn about the importance of being mission-driven and the mindset required for entrepreneurship.

“that we got on the direwolf that was negative.”

Facing the Challenges of Startups

29:38 to 30:11

Discover the reality of challenges faced by entrepreneurs and the importance of resilience.

“The luxury of freedom is more valuable to me than the pain and suffering in the darkest day.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00We've shown that the end-to-end system for de-extinction and species preservation works with what we've been able to achieve with our direwolves, as well as the work that we were able to do, our trait engineering with our woolly mice. So why do you want to bring back the woolly mammoth? There's not a better cultural animal icon than the mammoth, right? It almost feels like a dinosaur. People think that it went extinct 65 million years ago, but it's just out of human memory. Most people don't know this, but we were actually building the pyramids while mammoths still existed on this earth. And so the idea that we could bring back this icon and have this massive feat of science and inspire the next generation while also building technologies to help elephants is something that's pretty exciting.

0:49I don't know if there's a cooler science project on the planet. Before this podcast, I congratulate you on the last round, which is value the company at 10.3 billion. And you said we're just getting started. What did you mean by that? We've shown that the end-to-end system for de-extinction and species preservation works with what we've been able to achieve with our direwolves, as well as the work that we were able to do, our trait engineering with our woolly mice. And so if you look at how we scale genome engineering over the next, you know, two to 10 years, I think we're going to completely change what's possible in terms of synthetic biology.

1:25And so I think a lot of species that have gone extinct, you know, aren't just going to be on the verge of bringing back. I think we're going to see them back on this planet. And so I think over time, we'll have a whole kind of portfolio of animals that we've been able to bring back and hopefully successfully reintroduce in the ecosystem. So I think that Colossal, while people are excited and taking victory laps on the technology achievements and some of the financial achievements, we haven't even really started compared to where we think we're going. Tell me about the business model today and what you plan for the future.

1:57If you create a lot of value and you build a lot of technologies and you solve hard problems, you always find ways to monetize. So the original business model was, hey, if we go do this, there's probably something valuable along the way. We're now figuring that out, right? The midterm goal, which we're in right now, is spitting out technology companies, right? And so as we develop these different technologies and as we develop this pipeline for de-extinction, we're having to innovate across everything from like genome engineering to computational biology to cellular engineering to even cloning.

2:30And so all of those different technologies have different applications to human health care, to animal, to plants, all over the board. So we've successfully spun out three companies, two of which we've announced, right? The third one we haven't announced, which we're pretty excited about. And our first two companies are valued over$100 million, right? So I think we're starting to show that the value in not just the technology that we're developing, but as it can be packaged into a specific use case, a specific target company, is pretty interesting. And I think over time, we'll build more and more companies.

3:01Long term, what we're finding is that governments are now coming back, coming to us for everything from biobanking to genetic rescue and help saving species, as well as like what are the long term applications to rewilding the extinct species back, everything from carbon credits to ecotourism. So we're really looking at both the technologies and the animals as ways to monetize both short, mid and long term. Outside of ecotourism, carbon credits, is there potential pharmaceutical applications or other ways to improve humans through kind of these these de-extinction technologies? Our computational analysis and some of the tools we built were so interesting that we spun them out into a company called FormBio, which is focusing on how we can almost do drug resurrection, almost like de-extinction for drugs.

3:52So drugs that failed in the different stages of manufacturing or the clinical trials, we can actually help identify, use AI, use some of our modeling to understand why those drugs failed and hopefully resurrect them. We had a lot of success very quickly in that model with FormBio, which is pretty interesting. Other ideas that we're starting to employ is like, even though we don't have artificial wounds, our long-term goal is to actually grow everything fully ex-utero. So we have a pretty large team working on artificial looms. And even just the Lego blocks, if you will, that we're building towards artificial looms are massively valuable.

4:30What made you think, maybe I should start a de-extinction company? And what gives you the right to do that? I like hiring much smarter women than me. I like building systems. I like learning from people. So I thought that I would probably be the right person to kind of go figure this out. I didn't have backgrounds in some of the other technologies I'd built before. But then, you know, I think the other one is COVID, right? It's like we sat around and we're in like doing introspection. I'd built a handful of software companies. And so just doing something that didn't create like role, step, function, change, just creating new software company didn't seem that interesting.

5:02And the idea that we could build a company that created a lot of value, create impact for conservation, and then also inspire the next generation if we were successful about science, it just seemed like the right fit. And it seemed crazy enough to go do. And then I thought if it failed, I could just go back to software. So it really wasn't the worst case. Do you think the fact that you had had a couple of successes under your belt made you more likely to go after Moonshot? Having a couple of successes under my belt gave me probably some of the confidence, but I think it also really helped me understand the playbook and the context switching.

5:39I don't think that I could have built Colossal before I had done so many different startups because Colossal, most people think of as just being in the lab. We also spend so much time with governments. We spend so much time in the field. We spend so much time with conservation, indigenous people groups, legislators. There's so much complexity to this business, and there's a lot of context switching. So I really think that I needed that time and effort to really be prepared for everything that I have to do on a daily basis at Colossum. You're going at hyperspeed. How are you going so quickly and with so much complexity?

6:16And what are some of your secret sauces for building a fast-growing startup? We got to get the right team, right? I think that motivation also starts at the top, right? And so if I'm phony, then I think everyone else will phone it in. If I'm here, if I'm on the road, if I'm the first one in and the last one out, I think that tries to lead by example. I never ask anyone to do something I wouldn't do. And so if we need to go work on a project with Indigenous People Group in the South Island of New Zealand, I need to be able to get on a plane and do the same. There's many flights where I've gone halfway around the world for a 24-hour session.

6:53Right. And and and those are the things that I think that you have to be committed to do if you're going to ask others to do it. We have an awesome opportunity to create something that's never been created, to make history and inspire the next generation. And I think that that opportunity is infectious. And we've tried to build a combination of all of the right people from all these different walks of life that that want that and that they live it right. If you come in Colossal Labs, you'll see everything's branded Colossal. Everyone's wearing different. I'm wearing a Direwolf T-shirt today, but everyone's wearing a different Colossal hoodie or T-shirt.

7:31And everyone is really mission-focused. In my experience, as long as you continue to say mission-focused and that is your ultimate driving force, the rest of the staff and team help build you up. And you can't just be the only torchbearer. you have to be able to light that in everyone else. Even when I'm coming in pretty early here, there's already people in the lab already doing experiments. When I come in on the weekends, people are here working because this is so part of their identity and what they want in life. Instilling that in what I've found, drive success at pretty quick speeds. Keith or boy popularized this framework that you want to hire barrels that basically create their own projects and execute essentially mini CEOs within the company.

8:17versus bullets that are like one trick ponies that may be very reliable, but you give them tasks. Yeah. How do you think about that? And how much of Colossal's success could be attributed to bringing these barrels that are kind of these mini CEOs? We almost treat every single species like a product. And so we have species leads that are almost like the mini CEOs, to your point of that they have full autonomy. We do have cross-functional teams in computational biology and embryology and animal husbandry. But the core products teams that are driving the individual species are almost many CEOs, right?

8:53And so, you know, and then I have cross domain functionality in the C-suite in terms of like our chief science officer, our chief biology officer, and our chief animal officer and our VP of data. To your point is they're almost many CEOs, many of them, they run their own budgets, they do their own reporting, They make their own decisions. We have a weekly senior leadership meeting just to go through this, under which we make everyone submit and prepare a memo because just going to a meeting and talking isn't that interesting. And so we always have everyone that drafts a memo, fills it out before the meeting so that everyone has to have read it before.

9:29What weaknesses did you fix from Chaotic Moon and Hypergiant that's allowed you to become much more successful as Colossae? One problem we had at Hypergiant was we had very big ambitions. We were software focused, and then we moved into hardware, but we didn't bring in the right investors on the hardware front. It's software investors understand the software side. We're then moving into some satellite hardware and whatnot. They didn't understand that business. I think we did a good job of explaining it, but they're traditional software people. I think we spend an unnecessary amount of time in the education process, Whereas with Colossal, I spent a lot of time identifying investors that had the same vision, the same long term, the same risk profile, and that also understood the technology stack.

10:21And so most of my core investors in the early days had met with George Church on different topics. They weren't like what I didn't have to educate people on George or CRISPR or anything. Right. And so, so I think I did a really good job of investor alignment and managing and setting expectations with Colossal. Is that kind of like anti-selling? Like you stood for something and you were looking for people that aligned with you. I had a couple of investors and they're great folks that had been in my previous companies that when I told them about this, they were like, I don't get it. They're like, we don't get it.

10:56They're like, we'll give you money to go start another software thing, but like, we, we don't get like, we don't get this. We don't know if you should do this. And I was like, look, okay, well, this just isn't for you. I didn't really spend time selling them on it. Right. I was like, okay, this is what I'm going to do. I'm a trust, but verify guy. So I spent a lot of time leading up to this to ensure that I felt like the technology stack was good enough to get there before we took people's money and my money and other people's money. But but and so in that process, though, we still didn't have like monetization models.

11:29We didn't actually know the timelines. We had ideas of the timelines. We had big goals. But but we ultimately had to go work with investors that had that risk profile, that had that ambition, that knew that there'd be positive and negative feedback along the way. And so I wouldn't necessarily say it's anti selling. I think that I just quickly weeded out the people that this just wasn't a fit for. And I, I, I've said numerous times, this deal is just not for everybody. There's a very famous household name investor that, uh, that's not in this deal. One of the top people in the world, uh, it's not Elon, uh, but other people, someone else.

12:09And, uh, that, that from day one was like, I'm just concerned on like, you know, if things go wrong, how this could hurt my personal brand. And I just said, look, this just isn't for you. like it's okay like we're still friends but they i i don't need to get you comfortable with this this is either something that you're into or you're not at the series a at the seed you had to make a bet a what were your first principles in creating colossal at the time and also what did you know and what did you not know we knew that the technologies existed we knew that there were no science gate it's not like we had to solve like faster than light travel.

12:50It's not like, okay, we can get to Alpha Sensari if we solve faster than light travel, right? There was none of those moments. There wasn't this major science case. So I think that the biggest thing that we did was we broke down the science into engineering challenges. And we took a mindset that these were engineering problems. These were not science problems. These were not discovery problems. We knew that if that somatic cell nuclear transfer and cloning works. And we knew that would make it more efficient. We knew that computational analysis and understanding, uh, uh, uh, doing analysis of genomes and building reference genomes and comparative genomics.

13:29We know that works. We knew that editing genome engineering works. Now we had to get the right media conditions, right? For these different cells, we had to create stem cells, which we knew we could create using Nama Yaka factors and others. And so we knew that the individual technologies and science worked from a principle perspective, but we had to break it down into engineering steps. We took an engineering perspective and not a scientific discovery perspective. We didn't want to create a scientific think tank lab. We wanted to create something that could actually deliver products to market in the way that we think of software products, only these being biological products that the world would get excited about.

14:11You broke the internet with the woolly mammoth. You did the dire wolf, which is obviously a Game of Thrones character. You could argue the Tasmanian tiger is kind of like the Tasmanian devil from Looney Tunes. Tell me about how you use the media and memes to spread and lead to this circuitous, this positive loop for the company. What's interesting is that we found that every single person that we talked to, whether it's a parent in Iowa, a child, an indigenous person in the South Island of New Zealand or a celebrity, right, or the most one of the richest people in the world, they all have their favorite extinct species.

14:50They all have their favorite living species. And we wanted to build a brand that was like very pop culture focused that it's like, how do you make science fun again? Like, remember the days when we like, you know, may I know exactly how old you are, but when we when we did like volcanoes in class and like that Bill Nye genre that doesn't exist anymore in America in terms of like science, science. There's lots of science skepticism. There's not this science excitement. So we wanted to create like, how do we take the stigma out of of of science and in this academic elite, which it has become? And how do we add in like old school, like 1980s MTV?

15:30So we always joke that Colossal, if we nailed Colossal, it was like the merger of Harvard meets old school MTV. I know that sounds dumb, but that's actually like what we've always said from day one in terms of the brand, how we communicate. You know, we believe science is for everyone. We don't think that kids in this attention economy are sitting around reading nature and science and sell. we think they're on Instagram and TikTok. So it's like, how do we get people as excited about science as they are about influencers or the next episode of the Kardashians? And so that's how we had this attitude.

16:04And so part of that is like work with culture. I wish I could tell you, we said, oh, we're going to call the Hemsworth brothers because they're from Australia. We didn't do that. It actually worked exactly opposite. Like the Hemsworth brothers reached out to us where they heard about our project. They were excited about the thylacine in Tasman entirely. They're like, we're excited about conservation. How do we get involved? And we had this kind of like pop culture domino effect where people heard about our different animals and projects and wanting to attach themselves to it. And then that just drove more and more of the pop culture excitement because I think that these tastemakers get people more and more excited about all these different projects that we're working on, right?

16:44And so Dell PCs with Intel inside are built for the moments that matter, for the moments you plan and the ones you don't. Built for the busy days that turn into all-night study sessions. The moment you're working from a cafe and realize every outlet's taken. The times you're deep in your flow and the absolute last thing you need is an auto update throwing off your momentum. That's why Dell builds tech that adapts to the way you actually work. Built with long-lasting batteries so you're not scrambling for the closest outlet. And built an intelligence that makes updates around your schedule not in the middle of it.

17:16They don't build tech for tech's sake. They build it for you. Find technology built for the way you work at dell.com slash dellpcs. Built for you.

17:29It ended up turning into this positive flywheel of us achieving big scientific milestones, educating people in areas and in the channels they were in, like TikTok and Instagram and X and others, And then also talking about it with pop culture and celebrity, because that just also makes it more fun and exciting. And I bet we found this kind of like perfect, like smoothie blend of how to talk about it. And, you know, I'd say the vast majority of people were stoked about it, but, you know, including a lot of people in scientific community. But there's about 30 percent of the scientific community that also hates that we're doing.

18:13I don't think it's a coincidence that you see people that are doing these generational breaking technologies like Elon with SpaceX, Lake Shul from Supersonic. They're balancing this extreme level of complexity in their business with this extreme, I guess, like simplification of their vision. We want to colonize Mars. We want to make travel easier or more efficient. I think there's something powerful to be able to kind of dial up the complexity and also to make it very simple. preparing for this interview, I talked to a lot of people, including my wife, who's in real estate. And they actually knew of the meme of the woolly mammoth coming back.

18:51They didn't know about Colossal necessarily, but it had become so popular that they knew the concept, even if they didn't have a name to it. I was in Budapest last week and I met someone and I was getting introduced some people in the government who didn't know about the project or who didn't know about Colossal. And then they were like, oh wait, you're the dire wolf guy. And I was like, yeah, sure. That's what you want to say. Like, and so, and so to your point, like, you know, they, they are aware of the movement, even if they aren't necessarily, they know the name Colossal. Now we hope as a company, we changed that over time.

19:26Um, but I think people just knowing about it, given that, I mean, we're, we're literally four years old as of like two days ago. So given the fact that we are, you know, you know, pretty young and our journey. And there is so much worldwide awareness, even if it isn't all directly tied specifically to the Colossal brand, but on the mission is pretty cool. We have been very, very fortunate. We have, I think we have over half a trillion media impressions, which is insane. Like, you know, it's ludicrously insane, but I think that we have captivated the world in terms of the science, the art of the possible, the conservation benefits.

20:12I think we've done a really good job in that communication. Half a trillion in impressions. You know, if I do the math, I left a 60 impression per human being on the planet, which is crazy. And then you have a very specific business and investment case. How much do you think about having kind of the narrative for the general audience and having the business case align? I don't need my, you know, kid or some parents to understand how we're going to monetize, you know, multiplex editing for human health care. And what's interesting is I can't tell you the number of times numerous people, including some of our investors, have said, oh, my gosh, I've heard about this from my kids.

21:00Of those half a trillion media impressions, most of those aren't like Discovery Kids or Nat Geo Kids or Scholastic. We've been in all of those, but those are like kind of like one off, right? Like we're not like, you know, we're not like a household name like Sesame Street to kids. So what's interesting is the number of adults, whether it's for the business, end up becoming in as an investor on the business thesis or the just a general purpose interest that have heard about it. And they say to me, I, oh, I heard about this for my kids. And what's, so it's interesting is like 99.99 % of our, our media is like your general purpose media.

21:38It's New York times, it's time magazine, it's Rolling Stone, it's others. Um, but it's not, it's not these kids. It's not like we're targeting the kids stuff. So it's, what's interesting is that, that so many adults and parents, even though that, that, that general, that half a trillion media impressions are mostly to people like us, so many kids are finding out about it and learning about it in schools that they're now elevating it to their parents, which I find is interesting because we don't directly market, you know, to kids. We hope we inspire kids, but we don't have like colossal kids or anything like that yet.

22:15What's the next decade for colossal look like? In the next decade, we will see a couple of things. We will see all of our flagship species done. I think we'll have mammoths, thylacines moas dodos um i think we'll have all of them done we'll have them all back into uh the the environment on on some level probably not the mammoths because the number of years takes to get to reach maturity in elephants they'll stop probably being some type of managed care facility with with human intervention to a point but i do think that some of the other species will have been successfully rewilded which is exciting we will also see massive jumps in uh the artificial womb technology.

22:55De-extinction to me doesn't seem like science fiction, you know, just based on what we've achieved and where I know we are on these various projects. It just seems like a function of time on scale. I do think that some of the artificial womb stuff to get to the point that we can replicate and have a warehouse or lab that's growing, you know, a hundred northern white rhinos still feels a little science fiction to me. How do you encapsulate your vision for the future and a world where colossal has executed its vision to take a meme from jurassic park uh i think we our tagline is like the business of discovery but i think it should be something more like life finds a way yet we help it get there why is it important for for the world to have these extinct species back into the ecosystem all the ecological modeling and environmental modeling is like when you remove keystone species from environments, you have this tropic downgrade, you have this negative effect on the ecosystem.

23:55So there has been lots of modeling, not done, some now being done by us, but way before us done in terms of like how it applies to the benefit of the ecosystem with restoring these species. They all have different unique values they add to the ecosystem. It's not just about restoring them to the ecosystem. I think it's also about having a redundancy model for ecosystem collapse in the event that this six mass extinction continues. And right now, given that it's forecasted that we could lose up to half of biodiversity in the next 25 years, you know, I would rather have a de-extinction toolkit and not that's that's that's systematized and well optimized and not need it.

24:38then need a de-extinction toolkit and not have it, right? And so to draw on some of your SpaceX comments, I think it's better to have off-world contingencies for a planetary destruction event, right? Than not, right? People can say, oh, well, going to Mars is weird, but we know we learned a lot when we went to the stars and we built a lot of technologies to help humanity. But also, I think building redundancy models for consciousness, like what SpaceX and Elon doing is probably a pretty good idea. I think the same for biodiversity here on Earth is probably a pretty good idea. Tell me about how you align with later stages of a capital market and also maybe your capital markets plans.

25:25We get asked all the time if we're going to go public, when we're going to go public. Like, you know, if you look at the mass retail appeal of companies like SpaceX and Tesla and others, I think that we have something similar for that. You know, people want to bet on Colossal because they're excited about it. And, you know, I don't think everyone wants just the next streaming platform. Right. I think everyone's like, OK, we got enough streaming platforms. We have enough social media platforms. Do we really need another one? Do we need another Slack? Do we need another one of these things? Right.

Read the full transcript

25:55And so I think that we have mass retail appeal. So I do think that most investors, even in the later stages, can look at our half trillion media impressions and say, is there a retail story for IPO? And I think that the general perspective has been, yes, across the board from analysts to the big banks to the various big PE firms. With that said, I think that because we've been pretty thoughtful about capital raising and we're weirdly capital efficient for the work that we're doing, I think that people aren't just betting on me and the management team. But I think they're saying, OK, look, there's 30 ways to monetize this.

26:39If you look at content models like Mr. Beast and the incredible business that they've built, what's interesting is we have that fan favor. I think we could develop those types of model where I think we could build a very profitable business on just the content of what we are creating if we want to do that right. Previous guests and former partner at Excel and Menlo, Tyler Sosen, put it, there's never been a business that failed because it ran out of market share. A profitable business that grows, retains optionality, retains upside. you've been an entrepreneur now for more than two decades founding companies you've had a lot of dark times what strategies do you use in those dark times in order to keep going and what's your philosophy on how to survive the hard times there's something uh uh from a genomics genetics perspective that's just fundamentally broken in me and others where it's like i i'm okay with just no.

27:43And I'm also okay with a blank piece of paper. And both those things to some people are very unsettling. No and rejection to some people is like what they live their life on. I told some of our investors, this just isn't for everybody, right? Like we're not for everybody. We've had some feedback where there's a small percentage, there's about 4 % of the feedback that we got on the direwolf that was negative. And of that, about half of it, people wanted to argue about their roles. And I was like, well, then don't call them a direwolf. I'm fine with that. And I think that that acceptance also makes people more bad because I, it just, I don't, I've never viewed my model of one to persuade.

28:19It's, it's, I feel very convicted about my, my mission. And then it's just my job to educate. And in those dark times, if you take this attitude of education, Tony Robbins once told that to me that you'll never feel nervous on stage. If you, if you have an attitude that you have to go out on stage and you have to persuade, you feel like you have to sell something, well, then you're really, you know, there is pressure in that, right? If your job is to be convicted about what you're doing, be the most knowledgeable, and then your job is just to educate people. Well, then you don't, I don't feel that, that same pressure.

28:51And so in my most darkest times, I've always been mission convicted. A lot of successes in entrepreneurship is not magic. It's just work. And most people forget about the times where you run out of money. People forget about the times where you can't find product market fit. People read the positive headlines. But I think that true technology serial entrepreneurship takes massively dysfunctional individuals with high degrees of pain tolerance and maybe borderline sadist. For me, I've just always been super mission convicted. And it's like, you know, if I build something and it doesn't work, you know, like the worst thing can, you know, your investors aren't like, they're not animals.

29:36They're not going to come eat you. So it's like the worst case scenario is like you say you're sorry and go try again. The luxury of freedom is more valuable to me than the pain and suffering in the darkest day. So I've always really just tried to rely on, you know, other entrepreneurs because I think they really know what you're going through in those dark days when you have the worst day ever, which happens on a monthly basis, no matter how great your startup is. You always have the worst day ever once a month, at least in my experience. That's it for today's episode of How to Invest. If this conversation gave you new insights or ideas, do me a quick favor.

30:19Share with one person in your network who'd find it valuable or leave a short review wherever you listen. This helps more investors discover the show and keeps us bringing you these conversations week after week. Thank you for your continued support.

From the publisher

What kind of entrepreneur decides to bring back extinct species and why might that become one of the most important businesses of our lifetime?

In this episode, I talk with Ben Lamm, Co-Founder and CEO of Colossal Biosciences, about why de-extinction is not science fiction but an engineering problem — and how solving it is creating breakthrough technologies across biology, conservation, and medicine. Ben shares how Colossal evolved from a bold idea into a multi-billion-dollar platform, why mammoths, dire wolves, and dodos became cultural gateways into serious science, and how mission-driven companies can attract talent, capital, and public imagination at once.

More from How I Invest with David Weisburd

All 253 episodes
EP272: How a $10B Company Turned De-Extinction into a PlatformHow I Invest with David Weisburd · 30 min
Listen in VO